Rapid Flow Cytometry-Based Assay for the Functional Classification of MEFV Variants

Yoshitaka Honda1, Yukako Maeda1, Kazushi Izawa2

  • 1Department of Pediatrics, Faculty of Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Abstract

Insights

A new functional assay effectively evaluates pathogenic MEFV variants, aiding in diagnosing pyrin-associated autoinflammatory diseases (PAADs) and classifying subtypes. This method clarifies variant pathogenicity for better patient care.

Area of Science:

  • Genetics
  • Immunology
  • Molecular Biology

Background:

  • Pathogenic variants in the MEFV gene cause pyrin-associated autoinflammatory diseases (PAADs), including familial Mediterranean fever (FMF).
  • Accurate diagnosis relies on clinical and genetic analysis, but the pathogenicity of many MEFV variants remains unconfirmed due to a lack of functional evaluation.
  • This uncertainty hinders precise diagnosis and classification of PAAD subtypes.

Purpose of the Study:

  • To establish and validate a novel functional assay for assessing the pathogenicity of MEFV variants.
  • To correlate functional variant data with clinical phenotypes for improved PAAD classification.
  • To provide a reliable tool for evaluating previously uncharacterized MEFV variants.

Main Methods:

  • THP-1 monocytes were transfected with 32 MEFV variants and assessed for cell death upon stimulation with TcdA or UCN-01.
  • Hierarchical cluster analysis was used to classify variants based on their functional response signatures.
  • IL-1β secretion was compared between healthy controls and patients with the MEFV P257L variant using cell-based and THP-1 assays.

Main Results:

  • Disease-associated MEFV variants induced varying levels of cell death, dependent on caspase-1 activation, ASC speck formation, and IL-1β secretion.
  • The 32 MEFV variants clustered into 6 distinct groups, correlating well with known clinical phenotypes.
  • The novel THP-1-based assay demonstrated consistent results with established cell-based methods for evaluating MEFV P257L variant pathogenicity.

Conclusions:

  • The developed functional assay provides a rapid and comprehensive method for evaluating MEFV variant pathogenicity.
  • This assay aids in refining the classification of pyrin-associated autoinflammatory disease subtypes.
  • The findings support improved diagnostic accuracy and personalized treatment strategies for PAAD patients.